Metformin Protects Auditory Hair Cells from Gentamicin-Induced Toxicity in vitro

Andrea Glutz1, Katharina Leitmeyer, Cristian Setz

  • 1Department of Biomedicine, Head and Neck Surgery, University Hospital Basel, Basel, Switzerland.

Audiology & Neuro-Otology
|September 16, 2015
PubMed

Insights

Metformin, an antidiabetic drug, protects auditory hair cells from damage in a laboratory setting. This research suggests metformin may safeguard hearing by preventing hair cell death caused by certain toxins.

Area of Science:

  • Oto-pharmacology
  • Cell Biology
  • Neuroscience

Background:

  • Metformin is a widely prescribed antidiabetic medication.
  • Metformin activates AMP-activated protein kinase, inhibiting the mammalian target of rapamycin pathway.
  • Studies suggest metformin reduces intracellular reactive oxygen species.

Purpose of the Study:

  • To investigate the potential protective effects of metformin on auditory hair cells (HCs) in vitro.
  • To assess the impact of metformin on gentamicin-induced HC apoptosis.
  • To evaluate the safety of metformin on spiral ganglion neuronal survival.

Main Methods:

  • Utilized an in vitro rat model.
  • Exposed auditory hair cells to gentamicin in the presence and absence of metformin.
  • Assessed hair cell survival and spiral ganglion neuron outgrowth.

Main Results:

  • Metformin demonstrated a protective effect against gentamicin-induced apoptotic cell death in auditory hair cells.
  • Metformin did not exhibit toxic effects on spiral ganglion neuronal survival or outgrowth in vitro.
  • The drug appears to mitigate damage to sensory hair cells.

Conclusions:

  • Metformin shows promise as a protective agent for auditory hair cells against specific types of ototoxicity.
  • These findings suggest a potential therapeutic role for metformin in preventing or treating hearing loss associated with hair cell damage.
  • Further research is warranted to explore metformin's efficacy in vivo.